N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE VERSUS CLINICAL RISK SCORES FOR PROGNOSTIC STRATIFICATION IN HEART FAILURE PATIENTS

The estimation of the prognostic performance of the Seattle Heart Failure Model (SHFM) and Cardiac and Comorbid Conditions (3C-HF) scores, comparing it with a single assay of N-terminal fraction of pro-B-type natriuretic peptide(NT-proBNP), leads to investigate if the adding of NT-proBNP to scores